Background: Patients with left ventricular (LV) systolic dysfunction have an increased risk for
ventricular arrhythmias. Purpose: To summarize the evidence about benefits and harms of …

Life-saving shocks are the raisons d'être of implantable cardioverter-defibrillators (ICDs).
Paradoxically, shocks also cause much of the morbidity associated with ICDs. Consistently …

Abstract Background Implantable cardioverter-defibrillators (ICDs) reduce mortality in both
primary and secondary prevention, but are associated with substantial short-and long-term …

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …

ATP and Mortality in 69,000 ICD Patients Aims Antitachycardia pacing (ATP) is an effective
treatment for ventricular tachycardia (VT) and can reduce the frequency of shocks in patients …

Sudden death is probably the greatest challenge in modern cardiology. After reviewing its
history, we describe the epidemiology of sudden death and its associated diseases. We …

Aims Little is known about the optimal number of antitachycardia pacing (ATP) attempts to
programme in the fast ventricular tachycardia (FVT) zone. We sought to analyse the long …

Aims The aims of this study were to describe arrhythmias documented with an implantable
loop recorder (ILR) in post-acute myocardial infarction (AMI) patients with left ventricular …

Background Programming implantable cardioverter-defibrillators (ICDs) with a high-rate
therapy strategy has proven to be effective in reducing shocks and is associated with a …

Abstract Aims Implantable cardioverter defibrillators (ICDs) are efficient in reducing mortality
in patients with left ventricular systolic dysfunction. High-rate cut-off programming may be …